AstraZeneca announces winners of the 2023 R&D Postdoctoral Challenge

AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge and agreed to fund their postdoctoral positions at one of the Company’s strategic R&D centres in either Cambridge, UK, Gaithersburg or Boston, US or Gothenburg, Sweden.

Weakened innate immunity may increase risk of severe COVID-19

During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection.

October 24, 2023

Cognitive Dysfunction, Viral Persistence Studied First in New Long COVID Trials

The first two of the long-awaited long COVID clinical trials from the RECOVER initiative are underway, the NIH said. RECOVER-NEURO, which will study interventions for

August 1, 2023

Hiring in the European pharma industry drop by 33% in Q3 2023

Notably, Management Occupations jobs accounted for a 16% share of the European pharma industry’s total new job postings in Q3 2023, drop 39% over the

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.